Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedPal AILSE:MPAL EV-to-OCF is -5.72 as of Aug. 04, 2026. The stock has 1 warning sign investors should review. Among 682 Healthcare Providers & Services companies, MedPal AI ranks better than 81.38% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, MedPal AI's Enterprise Value is £24.61 Mil.
MedPal AI's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2026 was £-4.30 Mil. Therefore, MedPal AI's EV-to-OCF for today is -5.72.
The historical rank and industry rank for MedPal AI's EV-to-OCF or its related term are showing as below:
LSE:MPAL'
s EV-to-OCF Range Over the Past 10 Years
Min: -6.35 Med: 0 Max: -6.35
Current: -6.35
During the past 4 years, the highest EV-to-OCF of MedPal AI was -6.35. The lowest was -6.35. And the median was .
LSE:MPAL's EV-to-OCF is ranked better than 81.38% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.74
vs LSE:MPAL: -6.35
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
MedPal AI's share price for today is £0.031.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was £-0.030.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
MedPal AI EV-to-OCF Related Terms
MedPal AI EV-to-OCF Historical Data
* Premium members only.
The historical data trend for MedPal AI's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, MedPal AI's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedPal AI EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where MedPal AI's EV-to-OCF falls into.
MedPal AI's current Enterprise Value is £24.61 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2026 was £-4.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI (LSE:MPAL) has a EV-to-OCF of -5.72 as of Aug. 04, 2026. According to the industry distribution chart, MedPal AI ranks #127 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 18.6%.
Is MedPal AI's EV-to-OCF too high?
MedPal AI's current EV-to-OCF is -5.72. Based on the distribution chart, MedPal AI ranks #127 out of 682 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does MedPal AI's EV-to-OCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedPal AI ranks #127 out of 682 companies for EV-to-OCF. This places MedPal AI in the top 19% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 8.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.74, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedPal AI's current EV-to-OCF is -5.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current EV-to-OCF of -5.72. The current EV-to-OCF is -5.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current EV-to-OCF is -5.72 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MPAL has been successfully added to your 
